Identification and Assessment of Risks in Biobanking: The Case of the Cancer Institute of Bari
Abstract
:Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Biobank Characteristics
2.2. Operational Approach
3. Results
3.1. Natural Disaster Risk
3.2. Significant Inherent and Moderate Residual Risks
Compromising of Confidentiality/Integrity/Availability of Personal Data
3.3. Moderate Inherent and Moderate Residual Risks
3.3.1. Unusability of Cryopreserved Biological Material
3.3.2. Accidents of Researchers, Employees or Technicians in Laboratories and Cryogenic Rooms
3.4. Significant Inherent and Slight Residual Risks
3.4.1. Infringement of the Rules on the Conservation of Biological Material
3.4.2. Prolonged Interruption of BioBank Activities (without Compromising the Biological Material)
3.5. Moderate Inherent and Slight Residual Risks
3.5.1. Compromise of the Value of the Biological Sample
3.5.2. Loss of Data Related to Samples
4. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Simeon-Dubach, D.; Watson, P. Biobanking 3.0: Evidence based and customer focused biobanking. Clin. Biochem. 2014, 47, 300–308. [Google Scholar] [CrossRef] [PubMed]
- ISO/IEC 9001:2015; Quality Management Systems Requirements. ISO Published: Geneva, Switzerland, 2015. Available online: https://www.iso.org/obp/ui/#iso:std:iso:9001:ed-5:v1:en (accessed on 13 May 2022).
- Annaratone, L.; De Palma, G.; Bonizzi, G.; Sapino, A.; Botti, G.; Berrino, E.; Mannelli, C.; Arcella, P.; Di Martino, S.; Steffan, A.; et al. Basic principles of biobanking: From biological samples to precision medicine for patients. Virchows Arch. 2021, 479, 233–246. [Google Scholar] [CrossRef] [PubMed]
- Mouttham, L.; Garrison, S.J.; Archer, D.L.; Castelhano, M.G. A Biobank’s Journey: Implementation of a Quality Management System and Accreditation to ISO 20387. Biopreserv. Biobank. 2021, 19, 163–170. [Google Scholar] [CrossRef] [PubMed]
- ISO 20387:2018. Biotechnology-Biobanking-General Requirements for Biobanking. Available online: https://www.iso.org/obp/ui/#iso:std:iso:20387:ed-1:v1:en (accessed on 13 May 2022).
- Mayrhofer, M.T.; Prainsack, B. Being a member of the club: The transnational (self-)governance of networks of biobanks. Int. J. Risk Assess. Manag. 2009, 12, 64. [Google Scholar] [CrossRef]
- Parry-Jones, A.; Hansen, J.; Simeon-Dubach, D.; Bjugn, R. Crisis Management for Biobanks. Biopreserv. Biobank. 2017, 15, 253–263. [Google Scholar] [CrossRef] [PubMed]
- Munich, R. NATHAN World Map of Natural Hazards; Münchener Rückversicherungs-Gesellschaft: München, Germany, 2011. [Google Scholar]
- Laurie, G. Reflexive governance in biobanking: On the value of policy led approaches and the need to recognise the limits of law. Hum. Genet. 2011, 130, 347–356. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dove, E.S.; Avard, D.; Black, L.; Knoppers, B.M. Emerging issues in paediatric health research consent forms in Canada: Working towards best practices. BMC Med. Ethic. 2013, 14, 5. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Porteri, C.; Pasqualetti, P.; Togni, E.; Parker, M. Public’s attitudes on participation in a biobank for research: An Italian survey. BMC Med. Ethic. 2014, 15, 81. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Domaradzki, J.; Pawlikowski, J. Public Attitudes toward Biobanking of Human Biological Material for Research Purposes: A Literature Review. Int. J. Environ. Res. Public Health 2019, 16, 2209. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wolf, S.M.; Jd, B.N.C.; Van Ness, B.; Lawrenz, F.; Kahn, J.P.; Beskow, L.M.; Cho, M.K.; Christman, M.F.; Green, R.C.; Hall, R.; et al. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet. Med. 2012, 14, 361–384. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rychnovská, D. Anticipatory Governance in Biobanking: Security and Risk Management in Digital Health. Sci. Eng. Ethic. 2021, 27, 30. [Google Scholar] [CrossRef] [PubMed]
- Siu, L.L.; Lawler, M.; Haussler, D.; Knoppers, B.M.; Lewin, J.; Vis, D.J.; Liao, R.G.; Andre, F.; Banks, I.; Barrett, J.C.; et al. Facilitating a culture of responsible and effective sharing of cancer genome data. Nat. Med. 2016, 22, 464–471. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jackson, J.L.; Larson, E. Prevalence and commonalities of informed consent templates for biomedical research. Res. Ethic. 2016, 12, 167–175. [Google Scholar] [CrossRef] [Green Version]
- Johnson, T.; Kollnig, K.; Dewitte, P. Towards responsible, lawful and ethical data processing: Patient data in the UK. Internet Policy Rev. 2022, 11, 1–24. [Google Scholar]
- Akyüz, K.; Chassang, G.; Goisauf, M.; Kozera, Ł.; Mezinska, S.; Tzortzatou, O.; Mayrhofer, M.T. Biobanking and risk assessment: A comprehensive typology of risks for an adaptive risk governance. Life Sci. Soc. Policy 2021, 17, 1–28. [Google Scholar] [CrossRef] [PubMed]
- Sargsyan, K.; Jaksa, B.; Hartl, G.; Macheiner, T. Risk Management in Biobanks. In Risk Management and Assessment; Rocha, J., Oliveira, S., Capinha, C., Eds.; IntechOpen: London, UK, 2020. [Google Scholar] [CrossRef]
- Miranda, E.; Pye, H.; Buckingham, S.; Alves, A.; Rodriguez-Justo, M. Risk Assessment for Activity Regulated Under the Human Tissue Act: A Single Institution Experience. Biopreserv. Biobank. 2021. ahead of print. [Google Scholar] [CrossRef] [PubMed]
- Narita, A.; Ueki, M.; Tamiya, G. Artificial intelligence powered statistical genetics in biobanks. J. Hum. Genet. 2020, 66, 61–65. [Google Scholar] [CrossRef] [PubMed]
- Cuellar, L.K.; Friedrich, A.; Gabernet, G.; de la Garza, L.; Fillinger, S.; Seyboldt, A.; Koch, T.; Oven-Krockhaus, S.Z.; Wanke, F.; Richter, S.; et al. A data management infrastructure for the integration of imaging and omics data in life sciences. BMC Bioinform. 2022, 23, 61. [Google Scholar] [CrossRef] [PubMed]
- Bio-Banking and AI to Fight Cancer. Available online: https://www.i3p.it/en/news/biobanking-artificial-intelligence-fight-cancer-aibibank-project-given-green-light (accessed on 23 May 2022).
- Dubai to Open UAE’s First Robotic Biobank. Available online: http://wam.ae/en/details/1395303043226 (accessed on 23 May 2022).
Scale | Evaluation | Description | Reduction Factor |
---|---|---|---|
5 | Very effective |
| 0.1 |
4 | Effective |
| 0.3 |
3 | Moderately effective |
| 0.5 |
2 | Weak |
| 0.7 |
1 | Very weak |
| 0.9 |
0 | Absent |
| 1 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
De Palma, G.; Bolondi, G.; Tufaro, A.; Pelagio, G.; Brando, G.; Vitale, D.; Paradiso, A.V. Identification and Assessment of Risks in Biobanking: The Case of the Cancer Institute of Bari. Cancers 2022, 14, 3460. https://doi.org/10.3390/cancers14143460
De Palma G, Bolondi G, Tufaro A, Pelagio G, Brando G, Vitale D, Paradiso AV. Identification and Assessment of Risks in Biobanking: The Case of the Cancer Institute of Bari. Cancers. 2022; 14(14):3460. https://doi.org/10.3390/cancers14143460
Chicago/Turabian StyleDe Palma, Giuseppe, Giulia Bolondi, Antonio Tufaro, Giuseppe Pelagio, Giuseppe Brando, Daniela Vitale, and Angelo Virgilio Paradiso. 2022. "Identification and Assessment of Risks in Biobanking: The Case of the Cancer Institute of Bari" Cancers 14, no. 14: 3460. https://doi.org/10.3390/cancers14143460